Shopping Cart
- Remove All
- Your shopping cart is currently empty
Vulinacimab (HLX-06), an anti-VEGFR-2 monoclonal antibody (mAb), plays a pivotal role in cancer research due to VEGFR-2's significant involvement in angiogenesis, as well as the proliferation, survival, migration, and differentiation of endothelial cells, processes critical for tumor growth where VEGFR-2 is overexpressed [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder |
Description | Vulinacimab (HLX-06), an anti-VEGFR-2 monoclonal antibody (mAb), plays a pivotal role in cancer research due to VEGFR-2's significant involvement in angiogenesis, as well as the proliferation, survival, migration, and differentiation of endothelial cells, processes critical for tumor growth where VEGFR-2 is overexpressed [1]. |
Cas No. | 2250342-36-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.